Albany, NY -- (SBWire) -- 08/22/2016 --The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 – 2018, keeping 2011 as the base year.
Complete Report with TOC @ http://www.mrrse.com/implantable-drug-delivery-devices
The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions).
A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.
Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/899
Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
About MRRSE
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.
Implantable Drug Delivery Devices Market Is Expected to Grow at a CAGR of 8.8% by 2018
The Asian implantable drug delivery devices market held a market share of over 15% in 2011 and will register the fastest CAGR during 2012 to 2018 owing to economic development in emerging economies such as India and China.